Vaccines containing purified GM2 ganglioside elicit GM2 antibodies in melanoma patients (Q34619348)

3 August 2017

title

Vaccines containing purified GM2 ganglioside elicit GM2 antibodies in melanoma patients (English)

1 reference

3 August 2017

0 references

1 reference

6

L J Old

1 reference

3 August 2017

5

H F Oettgen

1 reference

3 August 2017

P O Livingston

1

1 reference

3 August 2017

E J Natoli

series ordinal

2

1 reference

3 August 2017

M J Calves

series ordinal

3

1 reference

3 August 2017

E Stockert

series ordinal

4

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 May 1987

1 reference

Proceedings of the National Academy of Sciences of the United States of America

3 August 2017

published in

1 reference

3 August 2017

volume

84

1 reference

3 August 2017

issue

9

1 reference

3 August 2017

page(s)

2911-2915

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=304770

3 August 2017

1 reference

Human melanoma antigen AH is an autoantigenic ganglioside related to GD2.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=304770

Myelin gangliosides in vertebrates

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=304770

GD3, a prominent ganglioside of human melanoma. Detection and characterisation by mouse monoclonal antibody

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=304770

Cancer immunology: the search for specificity--G. H. A. Clowes Memorial lecture

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=304770

Cell surface antigens of human malignant melanoma: definition of six antigenic systems with mouse monoclonal antibodies

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=304770

T-cell-mediated cytotoxicity against autologous malignant melanoma: analysis with interleukin 2-dependent T-cell cultures

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=304770

Localization of the gangliosides GD2 and GD3 in adhesion plaques and on the surface of human melanoma cells

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=304770

Identification of a human neuroectodermal tumor antigen (OFA-I-2) as ganglioside GD2

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=304770

Class 1 (unique) tumor antigens of human melanoma. Identification of a 90,000 dalton cell surface glycoprotein by autologous antibody

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=304770

Ganglioside GM2 as a human tumor antigen (OFA-I-1)

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=304770

Preparation and properties of antisera against the lipid-A component of bacterial lipopolysaccharides

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=304770

Approaches to augmenting the immunogenicity of the ganglioside GM2 in mice: purified GM2 is superior to whole cells.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=304770

A murine monoclonal antibody detecting N-acetyl- and N-glycolyl-GM2: characterization of cell surface reactivity

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=304770

Disialoganglioside GD2 distributes preferentially into substrate-associated microprocesses on human melanoma cells during their attachment to fibronectin

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=304770

Cell-surface antigens of melanoma recognized by human monoclonal antibodies

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=304770

Monoclonal antibodies to a glycolipid antigen on human neuroblastoma cells.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=304770

Cell-mediated cytotoxicity for cultured autologous melanoma cells

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=304770

Characterization of a human melanoma-associated ganglioside antigen defined by a monoclonal antibody, 4.2.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=304770

Detection of cell surface and intracellular antigens by human monoclonal antibodies. Hybrid cell lines derived from lymphocytes of patients with malignant melanoma

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=304770

Anti-ganglioside antibodies in multiple sclerosis

26 October 2018

1 reference

12 December 2020

Development of a new melanoma model in C57BL/6 mice

1 reference

12 December 2020

Serological response of melanoma patients receiving melanoma cell vaccines. I. Autologous cultured melanoma cells

1 reference

12 December 2020

Serological responses of melanoma patients to vaccines derived from allogeneic cultured melanoma cells

1 reference

12 December 2020

Comparison of approaches for augmenting the serologic response to the individually specific methylcholanthrene-induced sarcoma-Meth A: pretreatment with cyclophosphamide is most effective

1 reference

12 December 2020

Serological response of melanoma patients to vaccines prepared from VSV lysates of autologous and allogeneic cultured melanoma cells

1 reference

12 December 2020

Immunogenicity of melanoma-associated gangliosides in cancer patients

1 reference

12 December 2020

The serologic response to Meth A sarcoma vaccines after cyclophosphamide treatment is additionally increased by various adjuvants

1 reference

12 December 2020

The serologic response of patients with stage II melanoma to allogeneic melanoma cell vaccines

1 reference

12 December 2020

Identifiers

DOI

10.1073/PNAS.84.9.2911

1 reference

3 August 2017

0 references

1 reference

3 August 2017

1 reference